Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CICERO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.084
EU - Europa 5.200
AS - Asia 4.401
SA - Sud America 684
AF - Africa 114
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 6
Totale 21.517
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.938
SG - Singapore 1.498
RU - Federazione Russa 1.313
CN - Cina 1.226
IT - Italia 1.010
FI - Finlandia 689
DE - Germania 536
BR - Brasile 535
HK - Hong Kong 410
VN - Vietnam 403
GB - Regno Unito 300
UA - Ucraina 268
PL - Polonia 241
IE - Irlanda 218
FR - Francia 191
JP - Giappone 155
SE - Svezia 124
KR - Corea 118
IN - India 114
BD - Bangladesh 85
CA - Canada 79
IQ - Iraq 65
TR - Turchia 65
AR - Argentina 62
RO - Romania 54
BE - Belgio 53
NL - Olanda 48
ES - Italia 41
ZA - Sudafrica 33
MX - Messico 32
AT - Austria 31
UZ - Uzbekistan 28
MY - Malesia 26
PH - Filippine 25
AU - Australia 24
IR - Iran 22
VE - Venezuela 20
CI - Costa d'Avorio 18
SA - Arabia Saudita 18
ID - Indonesia 17
EC - Ecuador 16
CO - Colombia 15
MA - Marocco 15
CL - Cile 14
IL - Israele 13
PY - Paraguay 13
CZ - Repubblica Ceca 12
NP - Nepal 12
PK - Pakistan 12
JO - Giordania 11
LT - Lituania 10
AE - Emirati Arabi Uniti 9
TN - Tunisia 9
TW - Taiwan 9
CH - Svizzera 8
KZ - Kazakistan 8
DZ - Algeria 7
EG - Egitto 7
KE - Kenya 7
SI - Slovenia 7
CR - Costa Rica 6
DK - Danimarca 6
LB - Libano 6
SY - Repubblica araba siriana 6
AZ - Azerbaigian 5
GR - Grecia 5
HN - Honduras 5
JM - Giamaica 5
KG - Kirghizistan 5
KW - Kuwait 5
NO - Norvegia 5
PT - Portogallo 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
EU - Europa 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
SD - Sudan 4
UY - Uruguay 4
AM - Armenia 3
BY - Bielorussia 3
HU - Ungheria 3
NG - Nigeria 3
PE - Perù 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CM - Camerun 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
HR - Croazia 2
LV - Lettonia 2
MM - Myanmar 2
NI - Nicaragua 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
Totale 21.489
Salva come PNG Salva come JPEG
Città #
Ashburn 1.401
Fairfield 1.372
Singapore 1.001
Woodbridge 745
Chandler 686
Houston 564
Seattle 560
Wilmington 552
Ann Arbor 524
Cambridge 479
San Jose 424
Hong Kong 391
Palermo 266
Moscow 240
Dublin 212
Zgierz 209
Council Bluffs 205
Beijing 179
Medford 168
Santa Clara 151
Los Angeles 149
Tokyo 147
New York 145
Jacksonville 128
Ho Chi Minh City 124
Hefei 119
Altamura 116
Des Moines 114
Nanjing 108
Frankfurt am Main 107
Princeton 102
Hanoi 99
Helsinki 97
Lauterbourg 97
Dallas 94
The Dalles 93
Lawrence 89
San Diego 78
Dearborn 69
Boardman 56
Changsha 54
Buffalo 53
Brussels 51
Milan 50
São Paulo 50
Shenyang 49
Tulsa 49
London 48
Orem 41
Chicago 40
Phoenix 39
Ludwigshafen am Rhein 38
Nanchang 35
Nuremberg 34
Rome 34
Jinan 33
Hebei 32
Tianjin 32
Bremen 31
Seoul 31
Zhengzhou 30
Kumar 29
Jiaxing 28
Amsterdam 26
Denver 26
Guangzhou 26
Panama City 26
Chennai 25
Izmir 25
Da Nang 24
Baghdad 23
Montreal 23
Munich 23
Redwood City 22
Ningbo 21
Atlanta 20
Falls Church 20
Toronto 20
Berlin 19
Brooklyn 19
Columbus 19
Saint Petersburg 19
Stockholm 19
Tashkent 19
Seongnam 18
Shanghai 18
Warsaw 18
Abidjan 17
Haiphong 17
Poplar 17
Johannesburg 16
Rio de Janeiro 16
Verona 15
Auburn Hills 14
Pune 14
Venice 14
Vienna 14
Hangzhou 13
San Paolo di Civitate 13
Tehran 13
Totale 14.082
Salva come PNG Salva come JPEG
Nome #
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 341
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 333
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 310
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy 310
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 305
Psychological distress and quality of life in ostomy patients with colorectal cancer: A systematic review of the literature 303
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 298
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 297
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features 289
Relationship between anxiety level and radiological investigation. Comparison among different diagnostic imaging exams in a prospective single-center study 287
Co-expression of CD133+/CD44+in human colon cancer and liver metastasis 285
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 283
A headlight on liquid biopsies: a challenging tool for breast cancer management 280
Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study 279
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 279
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 274
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 270
Whatsapp messenger as a tool for the multidisciplinary management in everyday clinical practice 266
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 266
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 263
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 263
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 262
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 261
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 259
HSP10,HSP70 AND HSP90 IMMUNOHISTOCHEMICAL LEVELS CHANGE IN ULCERATIVE COLITIS AFTER THERAPY 256
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 253
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 253
Targeted Therapies in Hepatocellular Carcinoma 252
Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer 252
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy 250
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 250
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 249
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. 247
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 247
Monoclonal antibodies in gastrointestinal cancers 243
Circulating exosomal Hsp60 as a new marker of colon cancer. 241
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 241
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 236
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? 234
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 233
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 232
Characterization of γδ T cells in intestinal mucosa from patients with early onset or long standing inflammatory bowel disease and their correlation with clinical status 227
Studio di fase II con Taxotere + Doxorubicina liposomiale + Trastuzumab nel trattamento del carcinoma mammario metastatico c-erb-B2 positivo 220
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells 220
Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy 219
Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life 219
The patient-physician relationship in the face of oncological disease: A review of literature on the emotional and psychological reactions of patients and physician 213
WHATSAPP MESSENGER AS A REAL-TIME TOOL FOR A LONG-DISTANCE ACTIVITY OF A MULTIDISCIPLINARY 213
Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. 210
Primary Non-Hodgkin’s lymphoma of the parotid gland 210
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer 210
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 205
Well-being among Italian medical oncologists: An exploratory study 203
Vg9Vd2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies 202
Aminobisphosphonates as New Weapons for gammaDelta T Cell-Based Immunotherapy of Cancer 201
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer 199
Bortezomib: a new pro-apoptotic agent in cancer treatment. 197
Impact of combination chemotherapy on toxicity in ovarian cancer: Systematic revision of literature and meta-analysis 197
Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials? 196
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 195
Evaluation of predictive factors for i-CLARAS (intraoperative complications in laparoscopic renal and adrenal surgery): a multicentre international retrospective cohort study 194
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy? 192
The clinical efficacy of enzalutamide in metastatic prostate cancer: Prospective single-center study 190
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting 187
The Role of Couples' Attachment Styles in Patients' Adjustment to Cancer 187
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? 186
Raltitrexed plus levofolinic acid and bolus/continuous infusion 5- Fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas 185
Docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer: an italian clinical axperience 185
Does Exist A Correlation Between BMI and Gleason Patterns 4 and 5 At Prostate Biopsy? 184
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. 183
The Risk of Toxicities from Trastuzumab, Alone or in Combination, in an Elderly Breast Cancer Population 182
Geldanamycin and its derivatives as Hsp90 inhibitors 177
Cardiotossicità e Cardioprotezione. 176
Studio pilota sul valore predittivo dei livelli plasmatici di 9 fattori angiogenetici nella selezione di pazienti candidati alla biopsia prostatica 175
Heterogeneity and prognostic influence of tumor- infiltrating γδ T lymphocytes in colon cancer patients 174
Unusual case of dorsal vertebral metastases from a male breast cancer 174
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis 173
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vγ9Vδ2 T Cell-Mediated Cytotoxicity 173
Studio di fase II con Gemcitabine + Oxaliplatino in combinazione nel trattamento delle neoplasie delle vie biliari, pancreas e colecisti in fase metastatica. 172
Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer 171
Role of densitometric criteria in evaluation of effectiveness of antiangiogenic therapies in metastatic colorectal cancer: An Italian clinical experience 168
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 168
Correlation between leptin plasmatic levels in non-obese patients and detection rate at prostate biopsy”- Poster P147 160
The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience 155
Nivolumab in metastatic melanoma: good efficacy and tolerability in elderly patients 154
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 153
Tas-102 in metastatic colorectal cancer (MCRC): Efficacy, tolerability, and quality of life in heavily pretreated elderly patients: A real-life study 150
Emergenze metaboliche 149
Leptin plasma levels in patients undergoing prostate biopsy. a preliminary study in 50 patients 144
La terapia adiuvante nel carcinoma del colon: un update della lettaratura 140
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 139
Ramucirumab and its use in gastric cancer treatment 138
Evaluation of anxiety level in patients wating to undergo to diagnostic radiological exams 135
Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen 134
CORRELATION BETWEEN FIBRONECTIN GENE EXPRESSION AND LOCAL TOXICITY INDUCED BY ADJUVANT INTRAVESICAL THERAPY 128
Use of Eribulin mesylate as second-line therapy in elderly patients with HER/2 negative metastatic breast cancer (MBC): Efficacy, tolerability and Quality of Life 118
Avelumab in First Line Maintenance in Advanced Urothelial Carcinoma (aUC) in Elderly Patients: Efficacy, Tolerability, and Quality of Life in Real Life Setting 116
Treatment with abiraterone in metastatic castration-resistant prostate cancer patients progressing after docetaxel: A retrospective study 110
NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: A real-life study 109
An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer 105
Totale 21.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.243
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021320 0 0 0 0 0 0 0 0 0 0 150 170
2021/20221.532 70 308 65 96 78 73 91 107 157 130 127 230
2022/20231.912 196 381 38 235 217 260 84 154 189 11 99 48
2023/2024885 32 107 60 67 57 162 78 111 7 28 40 136
2024/20252.267 49 175 233 171 103 87 151 185 133 253 282 445
2025/20267.308 612 242 405 653 715 1.164 1.011 825 525 881 275 0
Totale 22.095